METHODS FOR TREATING SUBJECTS WITH ABDOMINAL OBESITY HYPERTRIGLYCERIDEMIA AND/OR IMPAIRED GLUCOSE

Abstract: the present description relates to a cb1 receptor inhibitor compound of formula i or a pharmaceutically acceptable salt thereof for the treatment of a patient population with abdominal obesity hypertriglyceridemia and impaired glucose.

Inventor(s): Glenn Crater, Francois Ravenelle, Michael Harvey

CPC Classification: A61K31/415 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250152557